Skip to content

Freeze-all Policy in Poor Responders

Fresh Versus Frozen Embryos for Infertility in the Poor Responders as Defined by the Bologna Criteria

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03999541
Enrollment
178
Registered
2019-06-26
Start date
2019-07-30
Completion date
2020-12-30
Last updated
2020-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility, Female

Brief summary

To compare the effects of fresh embryo transfers (ET) and elective frozen-thawed embryo transfer cycles in poor ovarian responders.

Interventions

OTHERFreeze-all policy

A policy of freezing all the embryos followed by subsequent thawed frozen embryo transfer

Sponsors

Al-Yasmeen Fertility and Gynecology Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Masking description

Blinding of the allocated intervention is not possible.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* All patients that fulfill the Bologna criteria \[at least 2 of the following 3 features must be present: (i) advanced maternal age or any other risk factor for POR; (ii) a previous POR; and (iii) an abnormal ovarian reserve test (ORT)\] * if the progesterone serum level was ≤1.5 ng/mL on the trigger day. * body mass index 18-32 kg/m2 * Both partners are able to provide written informed consent. * At least 1 good quality embryo on day 3 after egg collection on day 3 according to the Istanbul consensus (7-8 cells; with symmetric blastomeres and \<10% fragmentation by volume). * Endometrial thickness ≥8 mm on trigger day. * a normal uterine cavity on ultrasound. * IVF/ICSI with only fresh semen

Exclusion criteria

* Pre-implantation genetic testing is being planned. * if they had severe endometriosis, uterine pathology (myomas, adenomyosis, endocrinopathies, adhesions, acquired or congenital abnormalities), untreated tubal hydrosalpinges, ovarian tumor, recurrent spontaneous abortion, implantation failure after ≥ 2 fresh or frozen ET.

Design outcomes

Primary

MeasureTime frameDescription
Livebirth rate32 weeksThe proportion of women in the population who had at least one live baby.

Secondary

MeasureTime frameDescription
Pregnancy rate2 weeksPositive pregnancy test at two weeks +/- three days after embryo transfer
Clinical pregnancy rate6-8 weeksThe presence of at least one fetal heartbeat at ultrasound between six and eight weeks of gestation

Countries

Egypt

Contacts

Primary ContactYasmin Magdi, PhD
Yas.magdi@hotmail.com00201282313979

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026